Elranatamab-Bcmm (Anti-BCMA & CD3)
Product Specifications
CAS Number
2408850-14-4
Synonyms
ElrexfioTM, PF-06863135
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Elranatamab-bcmm is a bispecific T-cell engager (BiTE) monoclonal antibody that targets CD3 and B-cell maturation antigen (BCMA), promoting the recruitment and activation of T cells to effectively eliminate malignant myeloma cells. It is FDA-approved for the treatment of adults with relapsed or refractory multiple myeloma. MW: 145.44 KD.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
36024064 1.0 µg DNA
PARP11 Lentiviral Vector (Mouse) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 